Objective:
There is a lack of data about residual symptoms in Chinese patients with depression. The aim of this study was to evaluate the association of residual symptoms with social functional impairment in these patients.
Methods:
This was a multicenter cross-sectional study conducted in 11 hospitals in eight cities of China from September 2014 to April 2015. Residual symptoms and social functioning were assessed using the SDS, QIDS-SR16, Q-LES-Q-SF, and PHQ-15 scales. Logistic regression analysis was used to determine the factors associated with social functional impairment.
Results:
Among the 1503 patients, 915 (60.9%) had no functional impairment (SDS ≤6) and 588 (39.1%) showed functional impairment (SDS >6). Those with impairment had higher PHQ-15 scores (7.4 ± 4.8 vs. 4.0 ± 3.4, P < 0.0001), lower Q-LES-Q-SF scores (all items P < 0.0001), higher SDS scores (13.9 ± 5.7 vs. 2.8 ± 2.2, P < 0.0001), and higher scores for all QIDS dimensions (all P < .0001). The factors related to functional impairment included QIDS dimension 7 (loss of interest) (OR = 2.137, 95%CI 1.600-2.853, P < 0.0001), QIDS dimension 9 (mental anxiety) (OR = 1.627, 95%CI 1.215-2.180, P = 0.0011), QIDS dimension 3 (appetite) (OR = 1.502, 95%CI 1.141-1.977, P = 0.0037), QIDS dimension 8 (energy) (OR = 1.468, 95%CI 1.092-1.973, P = 0.0110), age (OR = 0.982, 95%CI 0.971-0.993, P = 0.0013), disease course (OR = -1.004, 95%CI 1.002-1.006, P = 0.0004), and QIDS dimension 1 (sleep disorders) (OR = 1.622, 95%CI 1.068-2.463, P = 0.0232).
Conclusion:
Compared with patients with normal social function, cases with impaired social function have more physical symptoms, more residual symptoms of depression, and less satisfaction with the quality of life. Residual symptoms are associated with social functional impairment in patients with depression.
Citing Articles
Lower creatinine levels are associated with an increased risk of depression: evidence from the China Health and Retirement Longitudinal Study.
Liu F, Zhong X, Wang C
Front Psychiatry. 2025; 16:1446897.
PMID: 40071279
PMC: 11894454.
DOI: 10.3389/fpsyt.2025.1446897.
Social function scores and influencing factors in patients with residual depressive symptoms.
Liao Z, Pu X, Zheng Z, Luo J
World J Psychiatry. 2025; 15(1):98630.
PMID: 39831007
PMC: 11684207.
DOI: 10.5498/wjp.v15.i1.98630.
Clustering and drivers of symptoms observed at week six after antidepressant treatment in depressed outpatients.
Danon M, Poupon D, Courtet P, Gorwood P
Eur Psychiatry. 2025; 67(1):e85.
PMID: 39819366
PMC: 11795446.
DOI: 10.1192/j.eurpsy.2024.1801.
Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review.
Pastuszak M, Cubala W, Jakuszkowiak-Wojten K, Kwasny A, Swieczkowski D, Galuszko-Wegielnik M
Neuropsychopharmacol Rep. 2025; 45(1):e12519.
PMID: 39783764
PMC: 11713126.
DOI: 10.1002/npr2.12519.
Pharmacotherapy guideline concordance for major depressive disorder and its link to functioning via symptom change.
Breitzig M, He F, Kong L, Liu G, Waschbusch D, Yanosky J
J Clin Transl Sci. 2024; 8(1):e123.
PMID: 39345696
PMC: 11428114.
DOI: 10.1017/cts.2024.562.
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration.
Pastuszak M, Cubala W, Kwasny A
Drugs Real World Outcomes. 2024; 11(4):565-571.
PMID: 39269606
PMC: 11589017.
DOI: 10.1007/s40801-024-00453-y.
Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study.
Zu S, Wang D, Fang J, Xiao L, Zhu X, Wu W
Brain Behav. 2024; 14(9):e70024.
PMID: 39262174
PMC: 11391025.
DOI: 10.1002/brb3.70024.
The Search for Consistency in Residual Symptoms in Major Depressive Disorder: A Narrative Review.
Pastuszak M, Cubala W, Kwasny A, Mechlinska A
J Pers Med. 2024; 14(8).
PMID: 39202019
PMC: 11355381.
DOI: 10.3390/jpm14080828.
Improving Mental Health Outcomes in Patients with Major Depressive Disorder in the Gulf States: A Review of the Role of Electronic Enablers in Monitoring Residual Symptoms.
Ahmed N, Reagu S, Alkhoori S, Cherchali A, Purushottamahanti P, Siddiqui U
J Multidiscip Healthc. 2024; 17:3341-3354.
PMID: 39010931
PMC: 11247372.
DOI: 10.2147/JMDH.S475078.
Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand.
Pitanupong J, Aunjitsakul W
Qual Life Res. 2023; 33(2):399-409.
PMID: 37851323
DOI: 10.1007/s11136-023-03527-6.
Residual insomnia in major depressive disorder: a systematic review.
Kwasny A, Wlodarczyk A, Dywel A, Szarmach J, Strandberg O, Cubala W
Front Psychiatry. 2023; 14:1190415.
PMID: 37398584
PMC: 10312086.
DOI: 10.3389/fpsyt.2023.1190415.
Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study.
Wang M, Wei Z, Huang Q, Yang W, Wu C, Cao T
BMC Psychiatry. 2023; 23(1):54.
PMID: 36658505
PMC: 9850523.
DOI: 10.1186/s12888-022-04513-x.
Program for education and enrichment of relational skills (PEERS) training for social skills and depressed mood intervention in young adult with depression: Study protocol for a randomized controlled trial.
Hua Y, Zhao Q, Shen J, Liu Y, Zheng L, Zhang M
Front Psychiatry. 2022; 13:993124.
PMID: 36172511
PMC: 9510920.
DOI: 10.3389/fpsyt.2022.993124.
Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression.
Yang H, Gao S, Li J, Yu H, Xu J, Lin C
Front Psychiatry. 2022; 13:915689.
PMID: 35958633
PMC: 9360322.
DOI: 10.3389/fpsyt.2022.915689.
Functional status and return to work in people with major depression: a 3-year national follow-up study.
Hong J, Lee C, Lee Y, Escorpizo R, Chiang Y, Liou T
Soc Psychiatry Psychiatr Epidemiol. 2022; 57(6):1179-1188.
PMID: 35150307
DOI: 10.1007/s00127-022-02240-y.
Interventions to Promote the Quality of Life and Psychological Well-being in Chronic and Developmental Psychopathologies.
Sorrenti L, Filippello P
Front Psychol. 2021; 12:640175.
PMID: 33643171
PMC: 7907596.
DOI: 10.3389/fpsyg.2021.640175.